BlackRock Fund Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $62.1M | Buy |
1,921,554
+239,173
| +14% | +$7.73M | 0.01% | 1541 |
|
|
2016
Q3 | $57.6M | Buy |
1,682,381
+90,693
| +6% | +$3.1M | 0.01% | 1481 |
|
|
2016
Q2 | $53.7M | Buy |
1,591,688
+9,454
| +0.6% | +$319K | 0.01% | 1441 |
|
|
2016
Q1 | $83.8M | Buy |
1,582,234
+18,120
| +1% | +$960K | 0.02% | 1102 |
|
|
2015
Q4 | $120M | Sell |
1,564,114
-94,879
| -6% | -$7.29M | 0.03% | 813 |
|
|
2015
Q3 | $68.2M | Buy |
1,658,993
+29,805
| +2% | +$1.22M | 0.02% | 1218 |
|
|
2015
Q2 | $115M | Buy |
1,629,188
+20,337
| +1% | +$1.44M | 0.03% | 869 |
|
|
2015
Q1 | $143M | Buy |
1,608,851
+83,449
| +5% | +$7.41M | 0.03% | 706 |
|
|
2014
Q4 | $135M | Buy |
1,525,402
+145,926
| +11% | +$12.9M | 0.03% | 702 |
|
|
2014
Q3 | $134M | Buy |
1,379,476
+24,952
| +2% | +$2.42M | 0.04% | 634 |
|
|
2014
Q2 | $124M | Buy |
1,354,524
+117,888
| +10% | +$10.8M | 0.04% | 715 |
|
|
2014
Q1 | $86.6M | Buy |
1,236,636
+30,179
| +3% | +$2.11M | 0.03% | 967 |
|
|
2013
Q4 | $69.4M | Buy |
1,206,457
+3,235
| +0.3% | +$186K | 0.02% | 1149 |
|
|
2013
Q3 | $57.8M | Buy |
1,203,222
+142,024
| +13% | +$6.83M | 0.02% | 1213 |
|
|
2013
Q2 | $30.8M | Buy |
+1,061,198
| New | +$30.8M | 0.01% | 1539 |
|